Bank of New York Mellon’s X4 Pharmaceuticals XFOR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-344,747
| Closed | -$81.5K | – | 4257 |
|
2025
Q1 | $81.5K | Hold |
344,747
| – | – | ﹤0.01% | 4004 |
|
2024
Q4 | $253K | Hold |
344,747
| – | – | ﹤0.01% | 3841 |
|
2024
Q3 | $231K | Sell |
344,747
-124,625
| -27% | -$83.4K | ﹤0.01% | 3858 |
|
2024
Q2 | $272K | Buy |
469,372
+133,398
| +40% | +$77.4K | ﹤0.01% | 3848 |
|
2024
Q1 | $467K | Sell |
335,974
-9,980
| -3% | -$13.9K | ﹤0.01% | 3557 |
|
2023
Q4 | $290K | Sell |
345,954
-128,739
| -27% | -$108K | ﹤0.01% | 3807 |
|
2023
Q3 | $517K | Sell |
474,693
-3,536
| -0.7% | -$3.85K | ﹤0.01% | 3523 |
|
2023
Q2 | $928K | Buy |
478,229
+307,036
| +179% | +$596K | ﹤0.01% | 3228 |
|
2023
Q1 | $149K | Hold |
171,193
| – | – | ﹤0.01% | 4002 |
|
2022
Q4 | $170K | Buy |
171,193
+31,497
| +23% | +$31.3K | ﹤0.01% | 4016 |
|
2022
Q3 | $239K | Hold |
139,696
| – | – | ﹤0.01% | 3942 |
|
2022
Q2 | $135K | Sell |
139,696
-916
| -0.7% | -$885 | ﹤0.01% | 4165 |
|
2022
Q1 | $246K | Buy |
+140,612
| New | +$246K | ﹤0.01% | 4128 |
|
2021
Q2 | – | Sell |
-54,365
| Closed | -$468K | – | 4470 |
|
2021
Q1 | $468K | Buy |
54,365
+2,065
| +4% | +$17.8K | ﹤0.01% | 3718 |
|
2020
Q4 | $336K | Buy |
52,300
+3,147
| +6% | +$20.2K | ﹤0.01% | 3784 |
|
2020
Q3 | $333K | Buy |
49,153
+1,252
| +3% | +$8.48K | ﹤0.01% | 3679 |
|
2020
Q2 | $447K | Buy |
47,901
+8,969
| +23% | +$83.7K | ﹤0.01% | 3535 |
|
2020
Q1 | $389K | Buy |
38,932
+6,219
| +19% | +$62.1K | ﹤0.01% | 3487 |
|
2019
Q4 | $350K | Buy |
32,713
+5,648
| +21% | +$60.4K | ﹤0.01% | 3739 |
|
2019
Q3 | $344K | Buy |
27,065
+13,075
| +93% | +$166K | ﹤0.01% | 3722 |
|
2019
Q2 | $210K | Buy |
+13,990
| New | +$210K | ﹤0.01% | 3902 |
|
2019
Q1 | – | Sell |
-25,452
| Closed | -$59K | – | 4249 |
|
2018
Q4 | $59K | Buy |
25,452
+10,056
| +65% | +$23.3K | ﹤0.01% | 4036 |
|
2018
Q3 | $25K | Sell |
15,396
-225
| -1% | -$365 | ﹤0.01% | 4185 |
|
2018
Q2 | $57K | Buy |
15,621
+3,259
| +26% | +$11.9K | ﹤0.01% | 4068 |
|
2018
Q1 | $283K | Buy |
+12,362
| New | +$283K | ﹤0.01% | 3811 |
|